Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
enVVeno Medical (NVNO)
NASDAQ:NVNO
Holding NVNO?
Track your performance easily
NVNO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.40 - $6.97
Previous Close$5.51
Volume49.59K
Average Volume (3M)90.17K
Market Cap
$73.45M
Enterprise Value$35.61M
Total Cash (Recent Filing)$39.07M
Total Debt (Recent Filing)$1.23M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Nov 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.49
Shares Outstanding13,330,000
10 Day Avg. Volume69,212
30 Day Avg. Volume90,167
Standard Deviation0.22
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.91
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
enVVeno Medical News
PremiumCompany Announcements
enVVeno Medical’s VenoValve Trial Shows Promising ResultsOwnership Overview
17.06% Insiders
5.33% Mutual Funds
21.84% Other Institutional Investors
55.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
NVNO FAQ
What was enVVeno Medical’s price range in the past 12 months?
enVVeno Medical lowest stock price was $3.40 and its highest was $6.97 in the past 12 months.
What is enVVeno Medical’s market cap?
Currently, no data Available
When is enVVeno Medical’s upcoming earnings report date?
enVVeno Medical’s upcoming earnings report date is Nov 07, 2024 which is in 74 days.
How were enVVeno Medical’s earnings last quarter?
enVVeno Medical released its earnings results on May 08, 2024. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.4 by $0.09.
Is enVVeno Medical overvalued?
According to Wall Street analysts enVVeno Medical’s price is currently Overvalued.
Does enVVeno Medical pay dividends?
enVVeno Medical does not currently pay dividends.
What is enVVeno Medical’s EPS estimate?
enVVeno Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does enVVeno Medical have?
enVVeno Medical has 13,330,000 shares outstanding.
What happened to enVVeno Medical’s price movement after its last earnings report?
enVVeno Medical reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.4. Following the earnings report the stock price went down -2.549%.
Which hedge fund is a major shareholder of enVVeno Medical?
Among the largest hedge funds holding enVVeno Medical’s share is Perceptive Advisors LLC. It holds enVVeno Medical’s shares valued at 3M.
---
enVVeno Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.66%
12-Months-Change
Fundamentals
Return on Equity
-61.28%
Trailing 12-Months
Asset Growth
27.77%
Trailing 12-Months
Company Description
enVVeno Medical
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
---
Technical Analysis
---